Related Experiment Video
Updated: Feb 17, 2026
10:21
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
913
Hypothesis: pathogenesis of systemic sclerosis.
1Department of Dermatology, Kanazawa University Graduate School of Medical Science and School of Medicine, Kanazawa, Japan. takehara@med.kanazawa-u.ac.jp
The Journal of Rheumatology
|April 3, 2003
Summary
Systemic sclerosis (SSc) fibrosis may involve a two-step process. Transforming growth factor-beta (TGF-beta) initiates early fibrosis, while connective tissue growth factor (CTGF) sustains it, offering new insights into SSc pathogenesis.
Area of Science:
- Fibrosis research
- Connective tissue disorders
- Immunodermatology
Background:
- Systemic sclerosis (SSc) is a fibrotic disorder where the exact pathogenesis remains incompletely understood.
- Transforming growth factor-beta (TGF-beta) is recognized as a key mediator in fibrosis, but a second factor is hypothesized.
- Connective tissue growth factor (CTGF) is implicated in fibrotic processes.
Purpose of the Study:
- To propose a hypothesis for the two-step pathogenesis of systemic sclerosis (SSc).
- To investigate the role of Connective Tissue Growth Factor (CTGF) as a second mediator in SSc fibrosis.
- To elucidate the sequential roles of TGF-beta and CTGF in the development and maintenance of SSc.
Main Methods:
- Analysis of CTGF mRNA expression in different stages of fibrotic lesions in SSc.
- Measurement of serum CTGF protein concentrations and correlation with clinical manifestations (skin sclerosis, lung fibrosis).
- Utilizing an animal model to study the effects of TGF-beta induction followed by CTGF application on fibrosis.
Main Results:
- CTGF mRNA was detected in fibrotic lesions but absent in early or atrophic lesions.
- Elevated serum CTGF levels correlated significantly with the severity of skin sclerosis and lung fibrosis in SSc patients.
- In the animal model, TGF-beta-induced fibrosis became persistent upon subsequent CTGF application.
Conclusions:
- A two-step hypothesis for SSc pathogenesis is proposed: TGF-beta initiates fibrosis, and CTGF maintains it.
- CTGF plays a crucial role in sustaining tissue fibrosis in systemic sclerosis.
- These findings suggest potential therapeutic targets for managing SSc progression.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
577
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
577
01:30Atherosclerosis I: Introduction
1.2K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.2K
01:23Cystic Fibrosis: Pathogenesis
898
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
898
01:24T Cell Types and Functions
2.7K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.7K
01:20Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
01:20The JAK-STAT Signaling Pathway
13.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.1K